Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans

M. Sarkar, Susan L Stewart, A. Yu, Moon S Chen, T. T. Nguyen, M. Khalili

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Asians Americans have a high burden of hepatitis B virus (HBV) associated hepatocellular carcinoma (HCC). HCC screening practices in this population are unknown. We aimed to investigate predictors and patterns of HCC screening and its impact on survival in HBV-infected Asian Americans. Clinical data were obtained from a retrospective cohort of 1870 HBsAg-positive Asians in San Francisco's safety net clinics. In 824 patients at-risk for HCC, screening (â¥1 imaging and/or AFP per year) decreased from 67% to 47% to 24% from the 1st to 2nd to 10th year after HBV diagnosis, respectively. AFP, imaging, and imaging plus AFP were used in 37%, 14%, and 49% during the first year after diagnosis, and imaging plus AFP increased to 64% by the 10th year. Among 1431 patients followed in 2007, age 40-64 years, female gender, cirrhosis, hepatologist evaluation, HBV diagnosis after 2003, and testing for HBeAg were associated with HCC screening. Of the 51 patients with HCC, more cirrhotics received screening and were diagnosed with early stage disease. Median survival following HCC diagnosis was higher in screened patients (1624 days vs. 111 days, P = 0.02). MELD score at HCC diagnosis (HR 1.2, 95% CI 1.1-1.3) and receipt of curative therapy (HR 0.3, 95% CI 0.08-0.94) were associated with survival. Screening rates in at-risk Asian Americans, particularly among noncirrhotics, were suboptimal and decreased over time. Among patients with HCC, receipt of prior screening improved survival, and this survival benefit was related to better liver function at HCC diagnosis and receipt of curative therapy.

Original languageEnglish (US)
Pages (from-to)594-600
Number of pages7
JournalJournal of Viral Hepatitis
Volume19
Issue number8
DOIs
StatePublished - Aug 2012

Fingerprint

Asian Americans
Hepatitis B
Hepatocellular Carcinoma
Survival
Hepatitis B virus
Safety-net Providers
Hepatitis B e Antigens
San Francisco
Hepatitis B Surface Antigens
Fibrosis

Keywords

  • cirrhosis
  • hepatitis B
  • liver cancer
  • mortality
  • safety net healthcare system

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases
  • Virology

Cite this

Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans. / Sarkar, M.; Stewart, Susan L; Yu, A.; Chen, Moon S; Nguyen, T. T.; Khalili, M.

In: Journal of Viral Hepatitis, Vol. 19, No. 8, 08.2012, p. 594-600.

Research output: Contribution to journalArticle

@article{fcd87083c98643bc9461156ebed7c477,
title = "Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans",
abstract = "Asians Americans have a high burden of hepatitis B virus (HBV) associated hepatocellular carcinoma (HCC). HCC screening practices in this population are unknown. We aimed to investigate predictors and patterns of HCC screening and its impact on survival in HBV-infected Asian Americans. Clinical data were obtained from a retrospective cohort of 1870 HBsAg-positive Asians in San Francisco's safety net clinics. In 824 patients at-risk for HCC, screening ({\^a}¥1 imaging and/or AFP per year) decreased from 67{\%} to 47{\%} to 24{\%} from the 1st to 2nd to 10th year after HBV diagnosis, respectively. AFP, imaging, and imaging plus AFP were used in 37{\%}, 14{\%}, and 49{\%} during the first year after diagnosis, and imaging plus AFP increased to 64{\%} by the 10th year. Among 1431 patients followed in 2007, age 40-64 years, female gender, cirrhosis, hepatologist evaluation, HBV diagnosis after 2003, and testing for HBeAg were associated with HCC screening. Of the 51 patients with HCC, more cirrhotics received screening and were diagnosed with early stage disease. Median survival following HCC diagnosis was higher in screened patients (1624 days vs. 111 days, P = 0.02). MELD score at HCC diagnosis (HR 1.2, 95{\%} CI 1.1-1.3) and receipt of curative therapy (HR 0.3, 95{\%} CI 0.08-0.94) were associated with survival. Screening rates in at-risk Asian Americans, particularly among noncirrhotics, were suboptimal and decreased over time. Among patients with HCC, receipt of prior screening improved survival, and this survival benefit was related to better liver function at HCC diagnosis and receipt of curative therapy.",
keywords = "cirrhosis, hepatitis B, liver cancer, mortality, safety net healthcare system",
author = "M. Sarkar and Stewart, {Susan L} and A. Yu and Chen, {Moon S} and Nguyen, {T. T.} and M. Khalili",
year = "2012",
month = "8",
doi = "10.1111/j.1365-2893.2011.01577.x",
language = "English (US)",
volume = "19",
pages = "594--600",
journal = "Journal of Viral Hepatitis",
issn = "1352-0504",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans

AU - Sarkar, M.

AU - Stewart, Susan L

AU - Yu, A.

AU - Chen, Moon S

AU - Nguyen, T. T.

AU - Khalili, M.

PY - 2012/8

Y1 - 2012/8

N2 - Asians Americans have a high burden of hepatitis B virus (HBV) associated hepatocellular carcinoma (HCC). HCC screening practices in this population are unknown. We aimed to investigate predictors and patterns of HCC screening and its impact on survival in HBV-infected Asian Americans. Clinical data were obtained from a retrospective cohort of 1870 HBsAg-positive Asians in San Francisco's safety net clinics. In 824 patients at-risk for HCC, screening (â¥1 imaging and/or AFP per year) decreased from 67% to 47% to 24% from the 1st to 2nd to 10th year after HBV diagnosis, respectively. AFP, imaging, and imaging plus AFP were used in 37%, 14%, and 49% during the first year after diagnosis, and imaging plus AFP increased to 64% by the 10th year. Among 1431 patients followed in 2007, age 40-64 years, female gender, cirrhosis, hepatologist evaluation, HBV diagnosis after 2003, and testing for HBeAg were associated with HCC screening. Of the 51 patients with HCC, more cirrhotics received screening and were diagnosed with early stage disease. Median survival following HCC diagnosis was higher in screened patients (1624 days vs. 111 days, P = 0.02). MELD score at HCC diagnosis (HR 1.2, 95% CI 1.1-1.3) and receipt of curative therapy (HR 0.3, 95% CI 0.08-0.94) were associated with survival. Screening rates in at-risk Asian Americans, particularly among noncirrhotics, were suboptimal and decreased over time. Among patients with HCC, receipt of prior screening improved survival, and this survival benefit was related to better liver function at HCC diagnosis and receipt of curative therapy.

AB - Asians Americans have a high burden of hepatitis B virus (HBV) associated hepatocellular carcinoma (HCC). HCC screening practices in this population are unknown. We aimed to investigate predictors and patterns of HCC screening and its impact on survival in HBV-infected Asian Americans. Clinical data were obtained from a retrospective cohort of 1870 HBsAg-positive Asians in San Francisco's safety net clinics. In 824 patients at-risk for HCC, screening (â¥1 imaging and/or AFP per year) decreased from 67% to 47% to 24% from the 1st to 2nd to 10th year after HBV diagnosis, respectively. AFP, imaging, and imaging plus AFP were used in 37%, 14%, and 49% during the first year after diagnosis, and imaging plus AFP increased to 64% by the 10th year. Among 1431 patients followed in 2007, age 40-64 years, female gender, cirrhosis, hepatologist evaluation, HBV diagnosis after 2003, and testing for HBeAg were associated with HCC screening. Of the 51 patients with HCC, more cirrhotics received screening and were diagnosed with early stage disease. Median survival following HCC diagnosis was higher in screened patients (1624 days vs. 111 days, P = 0.02). MELD score at HCC diagnosis (HR 1.2, 95% CI 1.1-1.3) and receipt of curative therapy (HR 0.3, 95% CI 0.08-0.94) were associated with survival. Screening rates in at-risk Asian Americans, particularly among noncirrhotics, were suboptimal and decreased over time. Among patients with HCC, receipt of prior screening improved survival, and this survival benefit was related to better liver function at HCC diagnosis and receipt of curative therapy.

KW - cirrhosis

KW - hepatitis B

KW - liver cancer

KW - mortality

KW - safety net healthcare system

UR - http://www.scopus.com/inward/record.url?scp=84863725678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863725678&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2893.2011.01577.x

DO - 10.1111/j.1365-2893.2011.01577.x

M3 - Article

C2 - 22762144

AN - SCOPUS:84863725678

VL - 19

SP - 594

EP - 600

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

SN - 1352-0504

IS - 8

ER -